@kitanokusuriya こんなのはありました↓ https://t.co/7CEherkZgY
1,400 followers
608 followers
This well conducted trial showed the lack of efficiency of rHuEPO in AKI. Optimal discussion also for optimizing resources.
339 followers
@DrMootravardhak @askrenal If you are voting Neither on the basis of Erythropoietin in Acute Kidney Injury trial , then you should know than iron deficiency patients were not excluded in either arms. Rephrasing, median baseline TSAT% in either arm were 12.
237 followers
RT @JonathanNefro: En daño renal agudo y hemoglobina <11gr/dL, administrar eritropoyetina 4,000 cada 72hr, no↓ la necesidad de transfusione…